Replies to post #6918 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Rolling, I dabble a bit here and there, looking for a similar scenario where the company is hiding very positive information and then start digging deeper for the motive. In Anip's it started in January 2012. I had spent time on a few stocks but none with the Libigel's potential.

I followed the Libigel story to refine my research process. When I started I knew little about patent, clinical trials or the SEC processes. So I have been teaching my self along the way. This has also cut into my available time to research other company's. It is not much different than working a major case, especially when you encounter something new. You have to do some research to understand what it is you have stumbled upon.

When I retire I can commit more time to researching more stocks and learn more about the other sectors. Its still a work in progress. However what I learned by following Libigel, should help me identify other opportunities.